Precision medicine in COPD: where are we and where do we need to go?

Venkataramana Sidhaye, Kristine Nishida, Fernando J. Martinez

Research output: Contribution to journalArticle

Abstract

Chronic obstructive pulmonary disease (COPD) was the fourth leading cause of death worldwide in 2015. Current treatments for patients ease discomfort and help decrease disease progression; however, none improve lung function or change mortality. COPD is heterogeneous in its molecular and clinical presentation, making it difficult to understand disease aetiology and define robust therapeutic strategies. Given the complexity of the disease we propose a precision medicine approach to understanding and better treating COPD. It is possible that multiOMICs can be used as a tool to integrate data from multiple fields. Moreover, analysis of electronic medical records could aid in the treatment of patients and in the predictions of outcomes. The Precision Medicine Initiative created in 2015 has made precision medicine approaches to treat disease a reality; one of these diseases being COPD.

Original languageEnglish (US)
JournalEuropean respiratory review : an official journal of the European Respiratory Society
Volume27
Issue number149
DOIs
StatePublished - Sep 30 2018

Fingerprint

Precision Medicine
Chronic Obstructive Pulmonary Disease
Electronic Health Records
Disease Progression
Cause of Death
Therapeutics
Lung
Mortality

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Precision medicine in COPD : where are we and where do we need to go? / Sidhaye, Venkataramana; Nishida, Kristine; Martinez, Fernando J.

In: European respiratory review : an official journal of the European Respiratory Society, Vol. 27, No. 149, 30.09.2018.

Research output: Contribution to journalArticle

@article{8609c86a90c643c4bb4ee8554d9f79fa,
title = "Precision medicine in COPD: where are we and where do we need to go?",
abstract = "Chronic obstructive pulmonary disease (COPD) was the fourth leading cause of death worldwide in 2015. Current treatments for patients ease discomfort and help decrease disease progression; however, none improve lung function or change mortality. COPD is heterogeneous in its molecular and clinical presentation, making it difficult to understand disease aetiology and define robust therapeutic strategies. Given the complexity of the disease we propose a precision medicine approach to understanding and better treating COPD. It is possible that multiOMICs can be used as a tool to integrate data from multiple fields. Moreover, analysis of electronic medical records could aid in the treatment of patients and in the predictions of outcomes. The Precision Medicine Initiative created in 2015 has made precision medicine approaches to treat disease a reality; one of these diseases being COPD.",
author = "Venkataramana Sidhaye and Kristine Nishida and Martinez, {Fernando J.}",
year = "2018",
month = "9",
day = "30",
doi = "10.1183/16000617.0022-2018",
language = "English (US)",
volume = "27",
journal = "European Respiratory Review",
issn = "0905-9180",
publisher = "European Respiratory Society",
number = "149",

}

TY - JOUR

T1 - Precision medicine in COPD

T2 - where are we and where do we need to go?

AU - Sidhaye, Venkataramana

AU - Nishida, Kristine

AU - Martinez, Fernando J.

PY - 2018/9/30

Y1 - 2018/9/30

N2 - Chronic obstructive pulmonary disease (COPD) was the fourth leading cause of death worldwide in 2015. Current treatments for patients ease discomfort and help decrease disease progression; however, none improve lung function or change mortality. COPD is heterogeneous in its molecular and clinical presentation, making it difficult to understand disease aetiology and define robust therapeutic strategies. Given the complexity of the disease we propose a precision medicine approach to understanding and better treating COPD. It is possible that multiOMICs can be used as a tool to integrate data from multiple fields. Moreover, analysis of electronic medical records could aid in the treatment of patients and in the predictions of outcomes. The Precision Medicine Initiative created in 2015 has made precision medicine approaches to treat disease a reality; one of these diseases being COPD.

AB - Chronic obstructive pulmonary disease (COPD) was the fourth leading cause of death worldwide in 2015. Current treatments for patients ease discomfort and help decrease disease progression; however, none improve lung function or change mortality. COPD is heterogeneous in its molecular and clinical presentation, making it difficult to understand disease aetiology and define robust therapeutic strategies. Given the complexity of the disease we propose a precision medicine approach to understanding and better treating COPD. It is possible that multiOMICs can be used as a tool to integrate data from multiple fields. Moreover, analysis of electronic medical records could aid in the treatment of patients and in the predictions of outcomes. The Precision Medicine Initiative created in 2015 has made precision medicine approaches to treat disease a reality; one of these diseases being COPD.

UR - http://www.scopus.com/inward/record.url?scp=85054097873&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054097873&partnerID=8YFLogxK

U2 - 10.1183/16000617.0022-2018

DO - 10.1183/16000617.0022-2018

M3 - Article

C2 - 30068688

AN - SCOPUS:85054097873

VL - 27

JO - European Respiratory Review

JF - European Respiratory Review

SN - 0905-9180

IS - 149

ER -